erdafitinib
janssen
['erdafitinib', 'pancreatic', 'basket trial']
 tumor agnostic efficacy of #erdafitinib in patients with #fgfr alt. #asco23 one of the largest tumor agnostic basket trials!! 217 patients with fgfr 1-4 alteration 2 median prior systemic therapies orr: 29.5% (prior therapy orr 10%) pancreatic cancer: 55.6% 
Medical Oncologist.Professor @MDAndersonNews. Author.Phase 1,GI Cancers.#pancreaticcancer, #biliarytractcancers. Tweets are my own